Programmed cell death ligand 1 expression associated with subtypes of post-transplant lymphoproliferative disorder among pediatric kidney transplant recipients.

Weinberg, Olga K; Pinkus, Geraldine C; Ramos-Gonzalez, Gabriel J; Agur, Timna; Rodig, Nancy M

Weinberg, Olga K; Pinkus, Geraldine C; Ramos-Gonzalez, Gabriel J; Agur, Timna; Rodig, Nancy M.

Affiliation

Weinberg OK; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Pinkus GC; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Ramos-Gonzalez GJ; Department of Surgery, Boston Children's Hospital, Boston, Massachusetts, USA.
Agur T; Department of Nephrology and Hypertension, Rabin Medical Center, Petah Tikva, Israel.
Rodig NM; Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.

Clin Transplant ; 37(12): e15134, 2023 12.

Article in En | MEDLINE | ID: mdl-37772613

Subject(s)

Epstein-Barr Virus Infections; Kidney Transplantation; Lymphoproliferative Disorders; Humans; Child; Retrospective Studies; Kidney Transplantation/adverse effects; B7-H1 Antigen/metabolism; B7-H1 Antigen/therapeutic use; Ligands; Epstein-Barr Virus Infections/etiology; Lymphoproliferative Disorders/diagnosis; Lymphoproliferative Disorders/etiology; Apoptosis

Key words

PD-L1; PTLD; kidney transplant; pediatric

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Epstein-Barr Virus Infections / Lymphoproliferative Disorders Type of study: Prognostic_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: Clin Transplant Journal subject: TRANSPLANTE Year: 2023 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google